Lyra Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYRA and other ETFs, options, and stocks.

About LYRA

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. 

CEO
Maria Palasis
CEOMaria Palasis
Employees
30
Employees30
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2005
Founded2005
Employees
30
Employees30

LYRA Key Statistics

Market cap
20.51M
Market cap20.51M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
Dividend yield
Average volume
3.63M
Average volume3.63M
High today
$19.45
High today$19.45
Low today
$15.00
Low today$15.00
Open price
$17.53
Open price$17.53
Volume
583.49K
Volume583.49K
52 Week high
$37.50
52 Week high$37.50
52 Week low
$3.81
52 Week low$3.81

People also own

Based on the portfolios of people who own LYRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.